---
$id: https://graph.org.ai/products/commodity/51142425
$type: Product
source: UNSPSC
code: "51142425"
title: "Dihydroergotamine methanesulfonate"
class: "51142400"
classTitle: "Drugs used for vascular and migraine headaches"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dihydroergotamine methanesulfonate

**UNSPSC Code**: 51142425
**Class**: [Drugs used for vascular and migraine headaches](Drugs used for vascular and migraine headaches.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonnarcotic analgesic and dopamine agonist with the molecular formula C33H37N5O5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81AXN7R2QT, chemically known as ergotoman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'.alpha.)-, monomethanesulfonate (salt), but more generally known as dihydroergotamine methanesulfonate, which bears US NIH Compound Identifier 10531. European Medicines Agency schedules dihydroergotamine methanesulfonate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07139MIG. Most nations, for tariff purposes, schedule dihydroergotamine methanesulfonate under HS 29396900. SMILES: C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4CCCCC4)NC(=O)[C@@H]5C[C@@H]6C7CCCC8C7C(C[NH]8)C[C@H]6N(C5)C.CS(=O)(=O)O.

